Form D · Biotechnology

Alchemia Oncology Pty Ltd

Eight Mile Plains, C3 · CIK 0001535439

Offering snapshot reported Dec 23, 2011 · SEC filing

Reported sold: $605K
Investors reported: 2
Minimum accepted: $250K
First sale: Nov 11, 2011

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Dec 23, 2011	Amendment	$604,935	$0vs Nov 25, 2011	2	SEC filing
Dec 23, 2011	Initial	$708,825	No comparison	2	SEC filing
Nov 25, 2011	Initial	$604,935	No comparison	2	SEC filing

Offering details

Securities: Equity
Exemptions: 06
Duration over one year: No
Business combination: No

Sales commissions: $23.3K
Finders' fees: $0
Form D file number: 021-169233

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Ladenburg Thalmann & Co	505

Source: Form D, filed Dec 23, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Melvyn Bridges	Director
Tracie Elizabeth Ramsdale	Director
Peter Michael Smith	Director, Executive
Charles Edwyn Walker	Executive
Nerolie Withnall	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

3 Hi Tech Court Brisbane Technology Park
Eight Mile Plains, C3, QLD 4113